Skin Biopsies in Chemotherapy-induced Neuropathy
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Multiple Myeloma, Peripheral Neuropathy
Both
Multiple Myeloma, Peripheral Neuropathy
Trial Information
Skin Biopsies in Chemotherapy-induced Neuropathy
Inclusion Criteria:
- Patients with multiple myeloma receiving bortezomib
Exclusion Criteria:
- Patients not able to provide informed consent
- Patients with coagulation disturbances or immunocompromised patients
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Principal Investigator
Joost L Jongen
Investigator Role:
Principal Investigator
Investigator Affiliation:
Erasmus MC
Authority:
Netherlands: Dutch Health Care Inspectorate
Study ID:
MEC2008-305
NCT ID:
NCT00956033
Start Date:
November 2008
Completion Date:
November 2011
Related Keywords:
- Multiple Myeloma
- Peripheral Neuropathy
- Cancer
- Peripheral Neuropathy
- Bortezomib
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Peripheral Nervous System Diseases
- Demyelinating Diseases
- Polyneuropathies
- Nerve Compression Syndromes
- Neurologic Manifestations
- Neurotoxicity Syndromes
Name | Location |
|---|
